209 related articles for article (PubMed ID: 18417567)
1. Vesicular stomatitis virus oncolysis of T lymphocytes requires cell cycle entry and translation initiation.
Oliere S; Arguello M; Mesplede T; Tumilasci V; Nakhaei P; Stojdl D; Sonenberg N; Bell J; Hiscott J
J Virol; 2008 Jun; 82(12):5735-49. PubMed ID: 18417567
[TBL] [Abstract][Full Text] [Related]
2. Oncolytic activity of vesicular stomatitis virus in primary adult T-cell leukemia.
Césaire R; Olière S; Sharif-Askari E; Loignon M; Lézin A; Olindo S; Panelatti G; Kazanji M; Aloyz R; Panasci L; Bell JC; Hiscott J
Oncogene; 2006 Jan; 25(3):349-58. PubMed ID: 16186807
[TBL] [Abstract][Full Text] [Related]
3. Cell cycle progression or translation control is not essential for vesicular stomatitis virus oncolysis of hepatocellular carcinoma.
Marozin S; De Toni EN; Rizzani A; Altomonte J; Junger A; Schneider G; Thasler WE; Kato N; Schmid RM; Ebert O
PLoS One; 2010 Jun; 5(6):e10988. PubMed ID: 20539760
[TBL] [Abstract][Full Text] [Related]
4. Progression of a vesicular stomatitis virus infection in primary lymphocytes is restricted at multiple levels during B cell activation.
Schmidt MR; Gravel KA; Woodland RT
J Immunol; 1995 Sep; 155(5):2533-44. PubMed ID: 7650383
[TBL] [Abstract][Full Text] [Related]
5. Targeting the apoptotic pathway with BCL-2 inhibitors sensitizes primary chronic lymphocytic leukemia cells to vesicular stomatitis virus-induced oncolysis.
Tumilasci VF; Olière S; Nguyên TL; Shamy A; Bell J; Hiscott J
J Virol; 2008 Sep; 82(17):8487-99. PubMed ID: 18579592
[TBL] [Abstract][Full Text] [Related]
6. Vesicular stomatitis virus infection alters the eIF4F translation initiation complex and causes dephosphorylation of the eIF4E binding protein 4E-BP1.
Connor JH; Lyles DS
J Virol; 2002 Oct; 76(20):10177-87. PubMed ID: 12239292
[TBL] [Abstract][Full Text] [Related]
7. Defective translational control facilitates vesicular stomatitis virus oncolysis.
Balachandran S; Barber GN
Cancer Cell; 2004 Jan; 5(1):51-65. PubMed ID: 14749126
[TBL] [Abstract][Full Text] [Related]
8. Development of recombinant vesicular stomatitis viruses that exploit defects in host defense to augment specific oncolytic activity.
Obuchi M; Fernandez M; Barber GN
J Virol; 2003 Aug; 77(16):8843-56. PubMed ID: 12885903
[TBL] [Abstract][Full Text] [Related]
9. The HIV envelope but not VSV glycoprotein is capable of mediating HIV latent infection of resting CD4 T cells.
Yu D; Wang W; Yoder A; Spear M; Wu Y
PLoS Pathog; 2009 Oct; 5(10):e1000633. PubMed ID: 19851458
[TBL] [Abstract][Full Text] [Related]
10. Role of CD40 ligand and CD28 in induction and maintenance of antiviral CD8+ effector T cell responses.
Andreasen SO; Christensen JE; Marker O; Thomsen AR
J Immunol; 2000 Apr; 164(7):3689-97. PubMed ID: 10725727
[TBL] [Abstract][Full Text] [Related]
11. Down-regulation of type I interferon receptor sensitizes bladder cancer cells to vesicular stomatitis virus-induced cell death.
Zhang KX; Matsui Y; Hadaschik BA; Lee C; Jia W; Bell JC; Fazli L; So AI; Rennie PS
Int J Cancer; 2010 Aug; 127(4):830-8. PubMed ID: 19957332
[TBL] [Abstract][Full Text] [Related]
12. Histone deacetylase inhibitors potentiate vesicular stomatitis virus oncolysis in prostate cancer cells by modulating NF-κB-dependent autophagy.
Shulak L; Beljanski V; Chiang C; Dutta SM; Van Grevenynghe J; Belgnaoui SM; Nguyên TL; Di Lenardo T; Semmes OJ; Lin R; Hiscott J
J Virol; 2014 Mar; 88(5):2927-40. PubMed ID: 24371063
[TBL] [Abstract][Full Text] [Related]
13. VSV-tumor selective replication and protein translation.
Barber GN
Oncogene; 2005 Nov; 24(52):7710-9. PubMed ID: 16299531
[TBL] [Abstract][Full Text] [Related]
14. Interferon Beta and Interferon Alpha 2a Differentially Protect Head and Neck Cancer Cells from Vesicular Stomatitis Virus-Induced Oncolysis.
Westcott MM; Liu J; Rajani K; D'Agostino R; Lyles DS; Porosnicu M
J Virol; 2015 Aug; 89(15):7944-54. PubMed ID: 25995245
[TBL] [Abstract][Full Text] [Related]
15. Retargeting Oncolytic Vesicular Stomatitis Virus to Human T-Cell Lymphotropic Virus Type 1-Associated Adult T-Cell Leukemia.
Betancourt D; Ramos JC; Barber GN
J Virol; 2015 Dec; 89(23):11786-800. PubMed ID: 26378177
[TBL] [Abstract][Full Text] [Related]
16. Experimental Evolution Generates Novel Oncolytic Vesicular Stomatitis Viruses with Improved Replication in Virus-Resistant Pancreatic Cancer Cells.
Seegers SL; Frasier C; Greene S; Nesmelova IV; Grdzelishvili VZ
J Virol; 2020 Jan; 94(3):. PubMed ID: 31694943
[TBL] [Abstract][Full Text] [Related]
17. Cell cycle requisite for vesicular stomatitis virus replication in T lymphocytes activated with concanavalin A.
Fujisawa H; Kumazawa Y; Ohtani A; Nishimura C
J Clin Lab Immunol; 1984 Jan; 13(1):41-6. PubMed ID: 6325697
[TBL] [Abstract][Full Text] [Related]
18. The production of vesicular stomatitis virus by antigen- or mitogen-stimulated lymphocytes and continuous lymphoblastoid lines.
Nowakowski M; Feldman JD; Kano S; Bloom BR
J Exp Med; 1973 Apr; 137(4):1042-59. PubMed ID: 4348276
[TBL] [Abstract][Full Text] [Related]
19. Replication and cytopathic effect of oncolytic vesicular stomatitis virus in hypoxic tumor cells in vitro and in vivo.
Connor JH; Naczki C; Koumenis C; Lyles DS
J Virol; 2004 Sep; 78(17):8960-70. PubMed ID: 15308693
[TBL] [Abstract][Full Text] [Related]
20. Vesicular stomatitis virus induces apoptosis in the Wong-Kilbourne derivative of the Chang conjunctival cell line.
Gallyas E; Seprényi G; Sonkoly E; Mándi Y; Kemény L; Megyeri K
Graefes Arch Clin Exp Ophthalmol; 2006 Jun; 244(6):717-24. PubMed ID: 16328428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
